NE Oncology Issue - April 2013 Jackisch C, et al. ESMO 2012:271P Background The primary analysis of the data from the HannaH study demonstrated that, in the neoadjuvant/ adjuvant setting, the pharmacokinetics and efficacy of a new fixed-dose...

NE Oncology Issue - February 2014 Following the 2013 European Cancer Congress (ECC) in Amsterdam, New Evidence interviewed Dr. Sunil Verma for his impressions of the first results from the TH3RESA study,1 which evaluated the efficacy and...

NE Oncology Issue - May 2014 Breast Cancer The decision of which treatment strategy to use for patients with breast cancer is based on multiple factors, including tumour surface markers and clinical factors. Molecular techniques, including...